Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma.

about

Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q47737291

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical significance of chemo ...... diffuse large B-cell lymphoma.

@en

Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin

@nl

type

Item

label

Clinical significance of chemo ...... diffuse large B-cell lymphoma.

@en

Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin

@nl

prefLabel

Clinical significance of chemo ...... diffuse large B-cell lymphoma.

@en

Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin

@nl

P1476

Clinical significance of chemo ...... diffuse large B-cell lymphoma.

@en

P2093

Jian-Kang Shen

http://www.w3.org/2001/XMLSchema#string

Jun-Min Li

http://www.w3.org/2001/XMLSchema#string

Shu-Qing Zhao

http://www.w3.org/2001/XMLSchema#string

Zi-Zhen Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance

Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

CXCR4 over-expression and survival in cancer: a system review and meta-analysis

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse

Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Diffuse large cell lymphoma.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1379077

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28952842

http://www.w3.org/2001/XMLSchema#string